• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

用致敏猪淋巴细胞治疗晚期膀胱癌。

The treatment of advanced bladder cancer with sensitized pig lymphocytes.

作者信息

Symes M O, Riddell A G, Feneley R C, Tribe C R

出版信息

Br J Cancer Suppl. 1973 Aug;1:276-84.

PMID:4804286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2149050/
Abstract

Sixteen patients with advanced carcinoma of the bladder were treated by infusion of immunized pig lymphocytes into the arterial blood supply of the tumour. Seven patients obtained definite benefit as assessed clinically and pathologically.

摘要

16例晚期膀胱癌患者接受了将免疫猪淋巴细胞注入肿瘤动脉血供的治疗。经临床和病理评估，7例患者获得了确切疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b01b/2149050/495d49569fa6/brjcancersuppl00059-0282-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b01b/2149050/3062466da5ca/brjcancersuppl00059-0279-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b01b/2149050/2add9996900c/brjcancersuppl00059-0280-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b01b/2149050/397fe3694736/brjcancersuppl00059-0280-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b01b/2149050/6c520992306d/brjcancersuppl00059-0281-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b01b/2149050/519861f8a50b/brjcancersuppl00059-0281-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b01b/2149050/495d49569fa6/brjcancersuppl00059-0282-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b01b/2149050/3062466da5ca/brjcancersuppl00059-0279-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b01b/2149050/2add9996900c/brjcancersuppl00059-0280-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b01b/2149050/397fe3694736/brjcancersuppl00059-0280-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b01b/2149050/6c520992306d/brjcancersuppl00059-0281-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b01b/2149050/519861f8a50b/brjcancersuppl00059-0281-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b01b/2149050/495d49569fa6/brjcancersuppl00059-0282-a.jpg

相似文献

1
The treatment of advanced bladder cancer with sensitized pig lymphocytes.用致敏猪淋巴细胞治疗晚期膀胱癌。
Br J Cancer Suppl. 1973 Aug;1:276-84.
2
The results of treatment of 1,475 patients with bladder carcinoma in the region of Amsterdam, The Netherlands.
Prog Clin Biol Res. 1988;260:347-56.
3
Bladder cancer: clinical practice.膀胱癌：临床实践
J Ky Med Assoc. 2009 Apr;107(4):129-33.
4
Proceedings: Combined treatment of bladder cancer with sensitized pig lymphocytes and radiotherapy.论文集：用致敏猪淋巴细胞和放射疗法联合治疗膀胱癌
Br J Radiol. 1975 May;48(569):414-5.
5
The treatment of advanced bladder cancer with sensitized pig lymphocytes.用致敏猪淋巴细胞治疗晚期膀胱癌。
Br J Surg. 1974 Oct;61(10):825-7. doi: 10.1002/bjs.1800611018.
6
[The evolution of papillary tumors of the bladder. (propos of 107 cases)].[膀胱乳头状瘤的演变。（基于107例病例）]
Maghrib Tibbi. 1981 Dec;3(4):773-9.
7
The management and outcome of bladder carcinoma in Ontario, 1982-1994.1982 - 1994年安大略省膀胱癌的管理与治疗结果
Cancer. 2000 Jul 1;89(1):142-51.
8
Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide.使用用人淋巴细胞抗原-A24特异性MAGE-3肽脉冲的自体树突状细胞对膀胱癌进行免疫治疗。
Clin Cancer Res. 2001 Jan;7(1):23-31.
9
Management of superficial transitional cell carcinoma of the bladder.膀胱浅表性移行细胞癌的管理
Semin Urol. 1993 Nov;11(4):193-204.
10
Superficial bladder cancer: decreasing the risk of recurrence.
Oncology (Williston Park). 1996 Nov;10(11):1617-24; discussion 1624, 1627-8.

引用本文的文献

1
Immersion in the search for effective cancer immunotherapies.全身心投入寻找有效的癌症免疫疗法。
Mol Med. 2021 Jun 16;27(1):63. doi: 10.1186/s10020-021-00321-3.

本文引用的文献

1
The Bristol Bladder Tumour Registry.
Br J Urol. 1969 Feb;41:Suppl:1-64.
2
The use of immunized pig lymph-node cells in the treatment of patients with advanced malignant disease.免疫猪淋巴结细胞在晚期恶性疾病患者治疗中的应用。
Br J Surg. 1973 Mar;60(3):176-80. doi: 10.1002/bjs.1800600303.